Cantor Fitzgerald Weighs in on Precigen FY2026 Earnings
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Precigen in a report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Kim anticipates that the biotechnology company will earn $0.11 per share for the year. Cantor Fitzgerald currently has a “Overweight” rating on the stock. […]
Precigen, Inc. (NASDAQ:PGEN – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Precigen in a report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Kim anticipates that the biotechnology company will earn $0.11 per share for the year. Cantor Fitzgerald currently has a “Overweight” rating on the stock. […]
-limited-logo-1200x675.png?v=20220228095611&w=240&h=240&zc=2){kind=logo}
